Drug
Tegoprazan clinical trials
Also written BLI5100 and CJ-12420.
- studies test it
- 63
- open now
- 15
- in phase 3
- 19
- first study started
- 2011
Keep track of what changes. Save the tegoprazan studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
63 studies that test it; most in 2020 (8)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2013 | 3 |
| 2015 | 5 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 5 |
| 2019 | 6 |
| 2020 | 8 |
| 2021 | 4 |
| 2022 | 6 |
| 2023 | 8 |
| 2024 | 4 |
| 2025 | 4 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 27
- Phase 2
- 4
- Phase 3
- 19
- Phase 4
- 11
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 49 · Other 14
HK inno.N Corporation (38) · Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. (7) · Braintree Laboratories (3) · Xijing Hospital of Digestive Diseases (1) · Zhang Xiaofeng,MD (1) · Pusan National University Hospital (1) · Seoul National University Hospital (1) · Seok Kyeong Oh (1)
Often tested with
Tested in the same studies.
Clarithromycin (5) · Amoxicillin (3) · Bismuth (2) · Esomeprazole (2) · Vonoprazan (2) · Naproxen (2) · Minocycline (1) · Edoxaban (1)
Studies
Open first, then newest update. How each study uses tegoprazan is read from its arms, and is right about nine times in ten.
Testing it · 63
- Tegoprazan-Aspirin Drug Interaction in Healthy Adult Male VolunteersNot yet recruitingPhase 1HK inno.N CorporationNCT07853248Written as Tegoprazan
- A Study to Evaluate Tegoprazan as a Diagnostic Tool for GERDNot yet recruitingPhase 4HK inno.N CorporationNCT07826455Written as Tegoprazan 50 mg
- Tegoprazan Versus Lansoprazole for Endoscopic Ulcer Healing in Bleeding Peptic UlcersRecruitingPhase 2Indonesia UniversityNCT07708545Written as Tegoprazan tablet
- Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke)RecruitingPhase 3Hanyang University Guri HospitalNCT07687706Written as Tegoprazan 50 mg
- A Study to Evaluate the Pharmacokinetics and Food-effect of IN-M00002 Tablet in Healthy Adult VolunteersNot yet recruitingPhase 1HK inno.N CorporationNCT07277712Written as Tegoprazan
- Head-to-head Study of Tegoprazan 50 mg BID Plus Amoxicillin 1 g TID vs. Vonoprazan 20 mg BID Plus Amoxicillin 1 g TID for H. Pylori EradicationRecruitingPhase 2/3First People's Hospital of HangzhouNCT07242456Written as Tegoprazan
- Effect of Tegoprazan for Elective Surgery Patients Under General AnesthesiaEnrolling by invitationPhase 4Seok Kyeong OhNCT06743243Written as Tegoprazan
- Clinical Trial for the Comparative Evaluation of Acid Suppression and Symptom Management of Gastroesophageal Reflux Disease With the Administration of Tegoprazan or PantoprazoleRecruitingPhase 4Carnot LaboratoriesNCT06991348Written as Tegoprazan
- Tegoprazan And Lansoprazole Effectiveness in Bleeding Peptic Ulcer TreatmentRecruitingNot applicableMario SteffanusNCT06894992Written as Tegoprazan
- PK, PD and Safety of Tegoprazan 12.5 mg After Oral Administration in Healthy SubjectsEnrolling by invitationPhase 1HK inno.N CorporationNCT06332638Written as Tegoprazan 12.5mg
- Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Tegoprazan vs EsomeprazoleNot yet recruitingPhase 4Hospital General de México Dr. Eduardo LiceagaNCT06318104Written as Tegoprazan
- Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy SubjectsNot yet recruitingPhase 1HK inno.N CorporationNCT06164834Written as Tegoprazan 25 mg
- A Study to Evaluate the Efficacy and Safety of Tegoprazan in GERD Patients With Nighttime HeartburnRecruitingPhase 4HK inno.N CorporationNCT05701540Written as Tegoprazan
- Comparison of Two Dual Therapies in the First-line Treatment of Helicobacter Pylori Infection （SHARE2301）RecruitingNot applicableYanqing LiNCT05870683Written as Tegoprazan
- Exploratory Study to Standard Triple Therapy With Tegoprazan(by Dose) in H. Pylori Positive PatientsRecruitingPhase 2HK inno.N CorporationNCT05933031Written as Tegoprazan 50 mg Triple Therapy
- A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Non-Erosive Reflux DiseaseCompletedPhase 3Braintree LaboratoriesNCT05587322Written as BLI5100
- Study to Evaluate the Safety, Efficacy of Tegoprazan for the Prevention of PUD in Patients on Treatment With NSAIDsCompletedPhase 3HK inno.N CorporationNCT04840550Written as Tegoprazan 25 mg
- A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive EsophagitisCompletedPhase 3Braintree LaboratoriesNCT05587309Written as BLI5100
- Tegoprazan-Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy for H. Pylori Infection (TATH-1)CompletedPhase 4Zhang Xiaofeng,MDNCT05647278Written as Tegoprazan 50 mg, tablets, orally, qd
- A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux DiseaseCompletedPhase 3Braintree LaboratoriesNCT05890001Written as BLI5100
See all 63 studies that test tegoprazan →
Given in every arm · 2 — tegoprazan is usual care beside what is tested
- Tegoprazan Plus Amoxicillin BID vs TID Regimens for H. Pylori Eradication（Frequency Adjusted Same-dose Therapy for H. Pylori）Not yet recruitingPhase 4First People's Hospital of HangzhouNCT07242443Written as Tegoprazan 50 mg
- Tegoprazan-Based Therapies for H. Pylori Eradication: A Randomized Controlled TrialCompletedNot applicableZhongshan Hospital (Xiamen), Fudan UniversityNCT06977841Written as Tegoprazan
As the comparator · 1 — what is tested is compared with tegoprazan
Codes
What other systems call tegoprazan · ClinicalTrials.gg INT001098
- MeSH (NLM) C000631239tegoprazanOne source NLM
- UNII (FDA) W017G7IF4STEGOPRAZANConfirmed FDA, NLM, Wikidata
- Wikidata Q27292116tegoprazanConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C152542TegoprazanOne source FDA
- DrugBank DB16690One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000631239 | tegoprazan | One source NLM |
| UNII (FDA) | W017G7IF4S | TEGOPRAZAN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27292116 | tegoprazan | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C152542 | Tegoprazan | One source FDA |
| DrugBank | DB16690 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.